NC Biomatrix

Game-changing treatment for intervertebral disc (IVD) degeneration.

Problem

74 to 85% of the population experience back pain at least once in their lives – of which the most prevalent cause is degenerative disc disease. NC Biomatrix wants to provide a credible, functional, alternative for the treatment of degenerative disc disease.

Solution

NC Biomatrix’s innovative product is a medical therapy able to restore the natural biomechanics of the spine, alleviating the common cause of low back pain. We want to focus on restoring function instead of symptom relief and provide a non-invasive treatment option that does not cost more than current practice.

Contact Us

Our Team

Robert Guilleaume, CEO

Prof Keita Ito, CSO

Dr Kelly Hoogesteijn-Stam, Regulatory Affairs manager

Wanda Meijst, Clinical Affairs

Dr Ileana Lindeman, COO

News from NC Biomatrix

DSM Biomedical and NC Biomatrix sign Memorandum of Understanding

Eindhoven, NL, 10 January 2021 DSM Biomedical, the unrivaled expert in biomaterial science aiming to solve the world’s healthcare needs through sustainable science, and NC

NC Biomatrix Admin January 10, 2022

NC Biomatrix strengthens and expands its team

NC Biomatrix has expanded and strengthened its management team as the company moves closer to initial pilot clinical validation for its VitaDisc product. Ms Wanda

NC Biomatrix Admin July 23, 2021

NC Biomatrix recieves MIT Haalbaarheid Grant 2021

Yesterday NC Biomatrix was awarded an MIT Haalbaarheid Grant 2021 to support the feasibility study for a further NC Biomatrix product to address the major

NC Biomatrix Admin July 16, 2021

NC Biomatrix TakeOff2 application granted by NWO

In the recent application round, the NWO approved the TakeOff2 application submitted by NC Biomatrix. The company will receive the 250.000€ TakeOff2 loan to perform

NC Biomatrix Admin July 12, 2021

Revealed: NC Biomatrix part of the Top 10 most ground breaking academic startups in NL

The ten winners of the prestigious Academic Startup Competition 2020 have been named as Bimini Biotech, DeNoize, Digi.Bio, IamFluidics, Kaminari Medical, Lusoco, NC Biomatrix, Taylor,

NC Biomatrix Admin November 25, 2020

NC Biomatrix bv selected as one of 20 finalists in the Techleap Program

NC Biomatrix has been selected as one of 20 finalists in the Academic Startup competition for 2020. We are honored by this selection and for

NC Biomatrix Admin October 8, 2020

Visit us in Eindhoven

We are located where the research is: TU Eindhoven.